Ixico (IXI)

 

IXI Share PerformanceMore

52 week high44.000 05/12/16
52 week low22.200 05/04/17
52 week change 4.000 (14.04%)
4 week volume56,241 27/10/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

IXICO wins contract to deploy biosensors in clinical trial

IXICO has signed a new contract with another leading biopharmaceutical company to support the use of wrist worn activ...

Contract to Deploy Biosensors in Clinical Trial

RNS Number: 6394W IXICO plc 16 November 2017 16 November 2017 IXICO plc ("IXICO" or the "Company") IXICO signs its first contract with a new biopharma customer to deploy biosensors in a late stage clinical trial for a psychiatric disorder Further expansion of IXICO's biopharma customer base and wearable biosensor technology IXICO plc (AIM: IXI), the dig...

IXICO set to exceed expectations

IXICO has reported revenue for the year ended 30 September of 3.7m (2016: 3.1m). The Company said the 0.6m increase over...

Trading Statement

RNS Number: 0775U IXICO plc 19 October 2017 19 October 2017 IXICO plc ("IXICO" or the "Company") Pre-Close Trading Update Double-digit revenue growth Three new contracts signed in September, including first wearables contract IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today provides the following pre-close trading update...

IXICO wins new contract to support clinical trial

IXICO has signed a new contract, with a top 15 global pharmaceutical company, utilising wrist worn activity sensors ('wear...

New contract to support Phase II clinical trial

RNS Number: 6071S IXICO plc 04 October 2017 4 October 2017 IXICO plc ("IXICO" or the "Company") IXICO signs new contract to deploy biosensors in a Phase II neurological clinical trial First commercial contract using IXICO's wearable biosensor technology IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today announces that it has si...

New contract in Huntington's disease

RNS Number: 0234S IXICO plc 28 September 2017 28 th September 2017 IXICO plc ("IXICO" or the "Company") New contract in Huntington's disease with US-based pharmaceutical company IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, today announces that it has signed a new contract with a customer for its technology enabled imag...

IXICO wins contract with biopharmaceutical company

IXICO, the digital technologies company serving neuroscience, has signed a new contract with a North American based bio...

Fundamental DataMore

EPS-8.7
Dividend yield0 %

Latest discussion posts More

  • Trading Statement

    Very promising trading statement today........ 'double digit revenue growth'.. 'strong performance'.. 'ahead of expectations'.. '3 new contracts including first wearables'.. ...
    19-Oct-2017
    Ding2dong
  • Rollercoaster

    Well, after the news this morning this all but disappeared down the toilet, but then the buyers moved in...... has some support after all. Been an interesting few weeks.
    20-Dec-2016
    Ding2dong
  • Re: Wow

    It would be nice to see 60p by the end of the week, now that it's got a little momentum. Pi
    4-Dec-2016
    pi4

Users' HoldingsMore

Users who hold Ixico also hold..
LLOYDS GRP.21%
TESCO18%
ROCKHOPPER15%
BP15%
RANGE RES.15%

Codes & Symbols

ISINGB00BCLY7L40
SymbolsIXI, LSE:IXI, IXI.L, IXI:LN, LON:IXI, XLON:IXI

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account